Triptan Quantity Limit

Similar documents
Triptans Quantity Limit Program Summary

Anti-Migraine Agents

Page: 1 of 6. Aimovig (erenumab-aooe) injection, Ajovy (fremanezumab-vfrm) injection, Emgality (galcanezumab-gnim)

Clinical Policy: Triptans Reference Number: CP.CPA.217 Effective Date: Last Review Date: Line of Business: Commercial

Pharmacy Medical Necessity Guidelines: Migraine Medications

Clinical Policy: Sumatriptan Reference Number: CP.CPA.260 Effective Date: Last Review Date: Line of Business: Commercial

Clinical Policy: Sumatriptan Reference Number: CP.HNMC.260 Effective Date: Last Review Date: Line of Business: Medicaid Medi-Cal

Drug Therapy Guidelines

Abortive Agents. Available Strengths. Formulary Limits. Tablet: 5mg, 10mg ODT: 5mg, 10 mg 25mg, 50mg, 100mg. 5mg/act, 20mg/act

UTILIZATION MANAGEMENT CRITERIA

Page: 1 of 5. Sumatriptan Tablets and Nasal Spray (Imitrex) / sumatriptan and naproxen sodium (Treximet tablets)

Clinical Policy: Triptans Reference Number: CP.CPA.217 Effective Date: Last Review Date: Line of Business: Commercial

ABORTIVE AGENTS. Average cost per 30 days. Form Limits SEROTONIN AGONISTS $ $ Reserved for treatment failure to either Sumatriptan PA; QL

Literature Scan: Triptans

Sumatriptan Injection (Imitrex / Alsuma / Sumavel / Zembrace)

Clinical Policy: Triptans Reference Number: CP.HNMC.217 Effective Date: Last Review Date: Line of Business: Medicaid Medi-Cal

Sumatriptan Injection (Imitrex / Alsuma / Sumavel / Zembrace)

Commercial Formulary and Utilization Management Program Updates for January 2017 Producer Communication #782 Issued November 10, 2016

ADVANCES IN MIGRAINE MANAGEMENT

Migranal Nasal Spray. Migranal Nasal Spray (dihydroergotamine) Description

ONZETRA XSAIL (sumatriptan) nasal powder

Regulatory Status FDA approved indication: Migranal Nasal Spray is indicated for the acute treatment of migraine headaches with or without aura (1).

Sumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets)

GA KS KY LA MD NJ NV NY TN TX WA Applicable X N/A N/A X N/A X X X X X X N/A N/A X *FHK- Florida Healthy Kids. ADHD Narcolepsy

Rexulti (brexpiprazole)

SUMAVEL DOSEPRO (sumatriptan succinate) solution for injection

90 dosage units per 90 days OR. Extended-release Formulations Ultram ER 90 dosage units per 90 days OR

Zomig. Zomig / Zomig-ZMT (zolmitriptan) Description

Medication For Migraine Chart: Table 1: Acute Treatment when the attack begins

Zomig. Zomig / Zomig-ZMT (zolmitriptan) Description

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Duragesic Patch (fentanyl patch) Prior authorization is not required if prescribed by an oncologist

COLUMBIA UNIVERSITY HEADACHE CENTER: NEW PATIENT QUESTIONNAIRE

HYSINGLA ER (hydrocodone bitartrate) Prior authorization is not required if prescribed by an oncologist.

Goals. Primary Headache Syndromes. One-Year Prevalence of Common Headache Disorders

Pre - PA Allowance. Prior-Approval Requirements LEVORPHANOL TARTRATE. None

Sumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets)

Short Clinical Guidelines: Headache, Key Points for Diagnosis and Treatment

Sumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets)

Pharmacy Updates Summary

ASEBP and ARTA TARP Drugs and Reference Price by Categories

Maxalt. Maxalt / Maxalt-MLT (rizatriptan) Description. Section: Prescription Drugs Effective Date: April 1, 2016

Clinical Learning Days November 10, 2017

BELBUCA (buprenorphine buccal film)

Headache A Practical Approach

Case Presentation. Case Presentation. Case Presentation. Truths about Headaches (2017) Most headaches were muscle-tension headaches

Proton Pump Inhibitors

Headache Questionnaire

Humira (adalimumab) DRUG.00002

OH, MY ACHING HEAD! I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE MANAGING HEADACHE IN THE OUTPATIENT SETTING SECONDARY HEADACHES

MORPHINE IR DRUG CLASS Morphine IR, Dilaudid IR (hydromorphone), Opana IR (oxymorphone)

Antiepileptics. Medications Comment Quantity Limit Carbamazepine. May be subject Preferred to quantity limit Epitol

Cyltezo (adalimumab-adbm) CG-DRUG-64, CG-DRUG-65

Xartemis XR (oxycodone / acetaminophen extended release)

Treatments for migraine

MIGRAINE UPDATE. Objectives & Disclosures. Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment.

Lost in Translation: Making Sense of Clinical Treatment Guidelines

STEP THERAPY CRITERIA

REFERENCE CODE GDHC106PIDR PUBLICAT ION DATE M ARCH 2014 MIGRAINE - GLOBAL DRUG FORECAST AND MARKET ANALYSIS TO 2023

Opioid Analgesic/Opioid Combination Products

Strategies in Migraine Care

Botox (onabotulinumtoxina) Dysport (abobotulinumtoxina) Xeomin (incobotulinumtoxina) Myobloc (rimabotulinumtoxinb)

GA KS KY LA MD NJ NV NY TN TX WA Applicable X X N/A N/A X N/A X X X X X X N/A N/A NA *FHK- Florida Healthy Kids. Androgens

Levorphanol. Levorphanol Tartrate. Description

Long-Acting Opioid Analgesics

Long-Acting Opioid Analgesics

Xeljanz (tofacitinib), Xeljanz XR (tofacitinib extended-release)

Opioid Analgesic/Opioid Combination Products

Vestibular Migraine. Information for patients and carers. Department of Neurology and Otolaryngology Aberdeen Royal Infirmary

Antipsychotic Medications Age and Step Therapy

RATIONALE FOR INCLUSION IN PA PROGRAM

Management of headache

OXYCODONE IR (oxycodone)

Neuromuscular Blocking Agents

~ ColumbiaDoctors Adult New Patient Intake Form Patient Information

Pegylated Interferon Agents for Hepatitis C

Stanley J. Krolczyk DO, RPH Assistant Professor of Neurology University of South Florida College of Medicine Tampa, Florida

RATIONALE FOR INCLUSION IN PA PROGRAM

Faculty Disclosure. Karen L. Bremer, MD. Dr. Bremer has listed no financial interest/arrangement that would be considered a conflict of interest.

Update on Diagnosis and Management of Migraines

Butrans (buprenorphine patch) Description. Section: Prescription Drugs Effective Date: October 1, 2017

IMITREX UTILIZATION MANAGEMENT CRITERIA

Levorphanol. Levorphanol Tartrate. Description

Remicade (infliximab) DRUG.00002

NB Drug Plans Formulary Update

Approach to a Patient with Headache

Nucynta IR. Nucynta IR (tapentadol immediate-release) Description

Drug Class Review Triptans

Treatment of Primary Headache Syndromes

RATIONALE FOR INCLUSION IN PA PROGRAM

Drug Class Review Triptans

TREXIMET UTILIZATION MANAGEMENT CRITERIA

ALOGLIPTIN STEP. Step Therapy Requirements Effective April 1, 2018

Preventive treatment of migraine. Rebecca Burch, MD Brigham and Women s Faulkner Hospital Harvard Medical School Boston, MA

Infliximab/Infliximab-dyyb DRUG.00002

2008 Migraine Update Migraine Update Migraine Update. Epidemiology. Yousef Mohammad MD., MSc. Epidemiology

NBPDP FORMULARY UPDATE

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Belbuca (buprenorphine buccal film) Belbuca (buprenorphine buccal film) Description

Transcription:

*- Florida Healthy Kids Triptan Quantity Limit Override(s) Quantity Limit Approval Duration 1 year Oral Tablets Axert (almotriptan) tablets Relpax (eletriptan) tablets 6 tablets (6.25 mg) 12 tablets (12.5 mg) 6 tablets (20 40 mg) 12 tablets (40 mg). Frova (frovatriptan) tablets 9 tablets Amerge (naratriptan) tablets 9 tablets Maxalt (rizatriptan) tablets Maxalt (rizatriptan) MLT tablets 12 tablets 3 tablets/unit of use carrying case PAGE 1 of 5 09/12/2017 WEB-PEC-0646-17

*- Florida Healthy Kids Imitrex (sumatriptan) tablets 9 tablets Zomig (zolmitriptan) tablets Zomig (zolmitriptan) ZMT Treximet (sumatriptan/naproxen sodium) tablets 3 tablets (5 mg) 6 tablets (2.5 mg) 9 tablets Nasal Sprays Imitrex (sumatriptan) Nasal Spray Box of 6 inhalers 6 inhalers per Onzetra Xsail (sumatriptan) nasal powder Box of 8 pouches, each pouch contains two 11mg nosepieces to 12 inhalers per. 1 kit per rolling 30 days to 2 kits per rolling 30 days if override are met. Zomig (zolmitriptan) Nasal Spray Box of 6 inhalers 6 inhalers per to 12 inhalers per. PAGE 2 of 5 09/12/2017

*- Florida Healthy Kids Injectables Alsuma (sumatriptan) Injection 2 pre-filled syringe auto injectors 4 syringes per to 8 syringes per. Imitrex (sumatriptan) Injection 2 syringes/stat dose systems 4 cartridges per to 8 cartridges per. Box of 5 single dose vials 5 vials per rolling 30 days. to10 vials per. Sumatriptan Injection 1, 2, 5 or 10 single dose vials 5 vials per rolling 30 days to 10 vials per Sumavel (sumatriptan) DosePro 6 pre-filled units 4 unit devices per Zembrace SymTouch (sumatriptan) 1 pre-filled syringe autojector Box of 4 pre-filled syringe autojectors to 8 unit devices per if override are met 8 syringes per to 16 syringes per 30 days if override are met PAGE 3 of 5 09/12/2017

*- Florida Healthy Kids Transdermal Zecuity (sumatriptan iontophoretic transdermal system) Box of 4 patches 4 patches per to 8 patches per QUANTITY LIMITS Injectable Override Quantity Limits: Alsuma (sumatriptan) - up to 8 syringes per Imitrex (sumatriptan) Injection - up to 8 cartridges or 10 vials per Sumatriptan Injection up to 10 vials per Sumavel (sumatriptan) DosePro up to 8 unit devices per Zembrace SymTouch (sumatriptan) up to 16 syringes per Oral Tablet Override Quantity Limits: Quantities up to 18 standard dosage units per Nasal Spray Override Quantity Limits: Quantities up to 12 standard dosage units per Quantities up to 2 kits per (Onzetra Xsail) Transdermal Override Quantity Limits: Quantities up to 8 patches per APPROVAL CRITERIA Qualified patients may be eligible for coverage of quantities above the standard available quantity. Quantity limit overrides will be considered for people who meet all of the following criteria: I. Individual has a diagnosis of migraine headache, AND II. Individual has had a previous trial and an inadequate response to one of the following daily preventive therapies (AAHA 2012/2015, ICSI 2013): A. A tricyclic antidepressant [such as but not limited to amitriptyline, doxepin ]; OR B. A beta blocker [such as but not limited to metoprolol tartrate, propranolol, timolol, atenolol, nadolol, nebivolol]; OR C. A calcium channel blocker [such as but not limited to nicardipine, verapamil]; OR D. An ACE inhibitor [such as but not limited to lisinopril]; OR PAGE 4 of 5 09/12/2017

*- Florida Healthy Kids E. An angiotensin receptor blocker (ARB) [such as but not limited to candesartan]; OR F. An alpha 2 agonist [such as but not limited to guanfacine (AAHA 2012)]; OR G. An antiepileptic [such as but not limited to divalproex sodium, sodium valproate, topiramate, carbamazepine, gabapentin]; OR H. Other select antidepressants [such as but not limited to venlafaxine]; OR I. Cyproheptadine (Periactin). State name Date effective State Specific Mandates Mandate details (including specific bill if applicable) Key References: Clinical Pharmacology [database online]. Tampa, : Gold Standard, Inc.: 2017. URL: http://www.clinicalpharmacology.com. Updated periodically. DailyMed. Package inserts. U.S. National Library of Medicine, National Institutes of Health website. http://dailymed.nlm.nih.gov/dailymed/about.cfm. Accessed January 30, 2017. DrugPoints System (electronic version). Truven Health Analytics, Greenwood Village, CO. Updated periodically. Lexi-Comp ONLINE with AHFS, Hudson, Ohio: Lexi-Comp, Inc.; 2017; Updated periodically. PAGE 5 of 5 09/12/2017